Introduction {#Sec1}
============

A good musculoskeletal health is crucial throughout the course of life. In childhood, it allows an optimal development \[[@CR1]\], since the acquisition of bone mass is significantly impacted by the muscle function \[[@CR2]\]. In adulthood, good musculoskeletal health is necessary to prevent disorders affecting quality of life as osteoporosis and sarcopenia \[[@CR3]\]. Then, in the aging process, optimal musculoskeletal health prevents the loss of functional performance and subsequently allows for better autonomy and preserve independence \[[@CR4]\]. Indeed, direct and harmful consequences of decreased musculoskeletal health exist, including sarcopenia and osteoporosis, resulting in an increased propensity for falls and fractures, hospitalizations and, ultimately, premature death \[[@CR5]--[@CR10]\].

A body of evidence proves that the two entities of bone and muscle are highly linked due to their many interactions and interconnections. Obviously, the most noticeable link is demonstrated by the mechanical influences between these two tissues in the theory that was developed by Harold Frost \[[@CR11]\]: There is a mechanical loading that is generated by the movement of the muscle on the bone, leading to a positive relationship between the lean masses and bone tissues. Dealing with this 'mechanostat' principle and on the "bone-muscle" unit in children and adults, different modulators can be considered, such as hormonal, nutritional, behavioral or environmental factors \[[@CR12], [@CR13]\].

From a clinical point of view, the link between lean mass and bone has already been demonstrated in many cross-sectional studies, as synthesized by a systematic review conducted in 2014 \[[@CR14]\]. Indeed, this work concluded that lean mass was significantly associated with bone mineral density (BMD), estimating an overall correlation coefficient of 0.39 (95% confidence interval (CI) 0.34--0.43). With regard to muscle strength, its significant cross-sectional link with BMD has already been established a few times in postmenopausal women \[[@CR15]--[@CR17]\], but the research regarding childhood or adulthood is much less plentiful. There is a similar finding regarding the link between BMD and muscle performance: some studies, especially those of participants over the age of fifty, showed a significant but moderate correlation between the quantity of bone and the physical performance of subjects \[[@CR18]--[@CR20]\].

However, fewer studies have investigated the longitudinal evolution of BMD with its parallel evolution of lean mass, muscle strength and physical performance. Therefore, we systematically recorded longitudinal studies exploring the relationship between the changes of BMD and the changes in muscle components (i.e., lean mass, muscle strength and physical performance) with the ultimate goal to synthetize the findings of each independent study using a narrative review or a meta-analysis when possible.

Methods {#Sec2}
=======

Each stage of our systematic review and meta-analysis rigorously respected the guidelines proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) \[[@CR21]\]. Our issue of interest was first correctly identified and defined using the following PICOS strategy: Population or disease - bone mass; Intervention - the effect of the passing of time (growth in the child, advanced age in the adult and the elderly); Comparator - Not applicable; Outcomes - Lean mass, muscle strength and physical performance; Study design - Prospective. Our goal was therefore to systematically search and summarize the studies describing the association between the changes in bone mass with regards to the changes in muscle function (i.e., lean mass, muscle strength and physical performance). A protocol has been developed and published on PROSPERO under the registration number CRD42018093813, where the analysis plan was specified. Subsequently, we went through the different stages detailed below: literature search, study selection, data extraction, quality evaluation, data synthesis and statistical analysis.

Literature search strategy {#Sec3}
--------------------------

The Ovid-MEDLINE (1946 to August 2017), Scopus (1960 to August 2017) and Ovid-Allied and Complementary Medicine Database (AMED) (1995 to August 2017) electronic databases were searched in August 2017, with an update in December 2018, to identify the relevant studies that assessed the prospective association between changes in bone mass and in muscle components. All of the databases of interest could not be searched due to logistical limits. But additionally, a search of systematic reviews and other syntheses of previous literature was also initiated to manually identify potentially relevant scientific references in the bibliography using the Ovid-Cochrane Database of Systematic Reviews, Ovid-ACP Journal Club and Ovid-DARE databases. The main keywords that were employed comprised terms as 'Bone Mineral Density, 'Lean mass', 'Muscle Strength', 'Physical Performance', and 'Prospective Study'. No limitation for the date was applied, but a restriction was set for English or French languages. The detailed search strategy with the key words that were applied in the Ovid interface is available in Table [1](#Tab1){ref-type="table"}. Table 1Search Strategy applied via Ovid1 Bone Density/29 (Musc\* adj2 Disabilit\*).ti,ab.2 (Bone adj2 Densit\*).ti,ab.30 Sarcopenia/3 (Bone adj2 Mineral adj2 (Densit\* or31 Sarcopenia.ti,ab.Content\*)).ti,ab.32 exp. Muscle Strength/4 Osteoporosis/33 (Muscle\* adj2 Strength\*).ti,ab.5 Osteoporos\*.ti,ab.34 (Hand adj2 Strength\*).ti,ab.6 Osteoporosis, Postmenopausal/35 (Grasp\* adj2 Strength\*).ti,ab.7 Osteoporos\* Postmenopausal.ti,ab.36 (Grip\* adj2 Strength\*).ti,ab.8 Bone Diseases, Metabolic/37 (Pinch\* adj2 Strength\*).ti,ab.9 (Bone adj2 Metabolic adj2 Disease\*).ti,ab.38 (Physical adj2 Performance\*).ti,ab.10 Osteopenia\*.ti,ab.39 (Physical adj2 Endurance\*).ti,ab.11 Bone Demineralization, Pathologic/40 (Endurance\* adj2 Physical adj2 Activit\*).ti,ab.12 Bone Demineralization\*.ti,ab.41 (Physical adj2 Abilit\*).ti,ab.13 (Bone adj2 Loss\*).ti,ab.42 (Physical adj2 Function\*).ti,ab.14 (Bone adj2 Decline\*).ti,ab.43 or/18--4215 (Bone adj2 Weakness\*).ti,ab.44 Cohort Studies/16 (Bone adj2 Wasting).ti,ab.45 Cohort Stud\*.ti,ab.17 or/1--1646 Cohort Analys\*.ti,ab.18 (Musc\* adj2 Tissue\*).ti,ab.47 Follow-Up Studies/19 (Muscle adj2 Mass\*).ti,ab.48 Follow Up Studi\*.ti,ab.20 (Lean adj2 Mass\*).ti,ab.49 Longitudinal Studies/21 (Lean adj2 Body adj2 Mass\*).ti,ab.50 Longitudinal Stud\*.ti,ab.22 (Lean adj2 Tissue\*).ti,ab.51 Prospective Studies/23 (Fat Free adj2 Mass\*).ti,ab.52 Prospective Stud\*.ti,ab.24 (Fat Free adj2 Body adj2 Mass\*).ti,ab.53 Prospective Change\*.ti,ab.25 (Muscle\* adj2 Loss\*).ti,ab.54 or/44--5326 (Muscle\* adj2 Decline\*).ti,ab.55 17 and 4327 (Muscle\* adj2 Weakness\*).ti,ab.56 54 and 5528 (Muscle\* adj2 Wasting).ti,ab.57 limit 56 to (english or french)

Study selection {#Sec4}
---------------

A first screening step, performed by two independent investigators, was based on title and abstract of each reference that was yielded by the literature search. This procedure allowed for the exclusion of irrelevant studies according to the strict eligibility criteria that are shown in Table [2](#Tab2){ref-type="table"}. Mainly, inclusion criteria included: (1) Longitudinal cohort studies, (2) interested about changes in bone mineral density and (3) changes in muscle function (i.e., lean mass, muscle strength or physical performance). For the second stage, the two investigators independently read the full texts of the articles that were selected by the initial screening, and they scrutinized the inclusion and exclusion criteria for the identified studies. Doubts and differences of opinion about a potential inclusion were settled following a discussion between the researchers, with the intervention of a third if necessary. Table 2Eligibility criteriaInclusion criteriaExclusion criteriaDesign/type of studyLongitudinal follow-up (with at least two evaluations) including retrospective cohortAnimal studiesGenetic studiesStudy protocolParticipantsBoth men and womenNo age restrictionNo restriction regarding ethnicityPopulation suffering from a specific pathologyPopulation benefiting of a treatment influencing muscle/bone statusPopulation presenting a particular clinical conditionPopulation benefiting from a preventive or therapeutic interventionDiseaseBone Mineral Density or Bone Mineral Content, regardless of the technique employed to assess it.OutcomeA measure of muscle mass, muscle strength and/or physical performance, regardless of the method used to assess it or the site of the measurement of muscle mass and strength.

Data extraction {#Sec5}
---------------

Relevant data were independently extracted by the two reviewers according to a standardized data extraction form, which was previously pretested on a sample of two studies. Discrepancies between the two collaborators were solved by discussion, with mediation from a third peer if needed. The following data were extracted: first author; journal name; year of publication; country; study objective; sociodemographic data; sample size; time of follow-up; tools and cut-offs used to assess bone and muscle components; statistical outcomes (i.e., correlation coefficient or β coefficient); adjustment factors (i.e., variables known to significantly impact bone and muscle health; conclusion; potential conflicts of interest and funding. Authors and coauthors were systematically contacted by email if one of these data were unavailable in their report.

Quality assessment {#Sec6}
------------------

All included studies were appraised for their methodological quality by two independent reviewers using the Newcastle-Ottawa Scale (NOS) for cohort studies; this scale was composed of three grades: group selection, comparability, exposure and outcome assessment. A maximum of 9 points could be granted, with a score of 9 thus representing the highest methodological quality. For this evaluation, disagreements between the two reviewers were resolved thanks to the opinion and advice of a third expert. The quality assessment was used to investigate its impact on pooled results.

Data synthesis and statistical analysis {#Sec7}
---------------------------------------

A descriptive analysis of the included studies has been performed under the format of a narrative report. Some data that were required for the meta-analysis were missing. To counter this, first and/or last authors were contacted by email for additional information. For each association of changes in BMD and changes in lean mass that was reported by at least three papers depending on the site of measurement (i.e., total hip, femoral neck, lumbar spine or total body), a meta-analysis was undertaken, combining the statistical results of each study to determine an overall effect size, which was expressed as a correlation coefficient r with its 95% confidence interval (CI) and *p*-value, reported visually through a forest plot. Six studies shared association results after their adjustments, meaning that these analyses computed in a multivariable model, yielding a β coefficient with its standard error. We have contacted all of the authors of the different studies that provided only the β coefficient to obtain the data concerning the coefficient of correlation r. Only one author sent us the new exact r value \[[@CR22]\]. In the other cases, we computed the correlation coefficient r from the β coefficient, following the formula proposed by Peterson and Brown, in 2009 \[[@CR23]\]. Indeed, as suggested by these authors, this method (i.e., finding the r from the β) generally generates an accurate estimate of the effect size, giving a definite advantage for completing the meta-analysis, considering that the sampling errors would be more numerous if we excluded studies simply because they did not report the correlation coefficient r \[[@CR23]\]. Since we assumed a priori that the correlation estimates could fluctuate across studies because of a real association in each study but also by chance (and, subsequently, sampling variability), we used random-effects models to combine the results of the studies to find a pooled effect size, using the Hedges-Olkin method to calculate the overall correlation coefficient. Moreover, the statistic test I^2^, an estimator of inconsistency, as well as the χ^2^ test allowed for us to explore the heterogeneity \[[@CR24]\]. A one-way sensitivity analysis was also performed to evaluate the consistency of our results when omitting one study at a time, and we repeated this process for each study. This one-study removed method, usual sensitivity analysis for meta-analysis, can help to identify a specific study as a source of heterogeneity. A subgroup analysis was conducted because of the assumption of differences based on the life-course position of the individuals who were evaluated (i.e., children or older adults). Difference between groups was assessed by performing a Q-test based on analysis of variance. To investigate potential other sources of heterogeneity modifying the association between the evolution of bone mass in parallel with that of lean mass, we computed meta-regression models, which are composed of different moderators: mean age, quality of study, length of follow-up and sex of participants studied. To estimate the presence of a potential publication bias, we did not visually inspect the funnel plots since less than 10 studies were included in the different meta-analyses, but we instead used the Egger's regression asymmetry test to detect it. In each statistical result, a *p*-value equal or less than the 5% critical level was considered as statistically significant. All processes that were undertaken for the meta-analysis were realized using the software package Comprehensive Meta-Analysis, version 2 (Biostat, USA).

Results {#Sec8}
=======

Rendering of our literature search {#Sec9}
----------------------------------

The search through the literature yielded 1889 relevant references, after removing 49 duplicates. We additionally found, by handsearch, 3 relevant studies. From these 1892 articles, after a long process of review and discussion (Fig. [1](#Fig1){ref-type="fig"}), fifteen studies were finally included \[[@CR22], [@CR25]--[@CR38]\], detailed as follows: Fig. 1Detailed literature search flow diagram

\- 10 studies examining the link between evolution of lean mass and evolution of bone mass;

\- 4 studies focusing on the link between evolution of muscle strength and evolution of bone mass;

\- 1 study dealing with the link between evolution of physical performance and evolution of bone mass.

At the end of December 2018, we made an update to our search and relaunched our search strategy within the databases. No new relevant references were identified for our subject of interest.

Characteristics of the included studies {#Sec10}
---------------------------------------

The general characteristics of the 15 references included are detailed in Table [3](#Tab3){ref-type="table"}. These studies were published between 1997 and 2015. The population of interest was children or young adults for 5 studies \[[@CR25]--[@CR27], [@CR32], [@CR33]\], and the population of interest of the other studies were in female around the menopause age or individuals from the older age (i.e., older women and/or older men). With regards to the gender of the participants, 10 studies only focused on female subjects, 2 studies on male subjects only \[[@CR27], [@CR39]\], and 3 other studies consisted of a population of both men and women \[[@CR32], [@CR33], [@CR37]\]. The duration of follow-up of these longitudinal studies ranges from 1 year to 10 years. The instrument that was used to assess bone and lean mass was the Dual Energy X-ray Absorptiometry (DXA) device. Muscle strength was measured with a handgrip dynamometer \[[@CR28], [@CR29], [@CR38]\] or a chair dynamometer \[[@CR26]\] and the physical performance was established on the basis of a standard walk test of 5 m \[[@CR31]\]. One study recorded conflicts of interest \[[@CR22]\], 6 others recorded no conflict of interest, and 8 manuscripts did not mention the presence or absence of it. Additionally, 14 out of 15 studies are funded by a foundation, ministry, grant or national institute, and a single \[[@CR40]\] study does not report whether or not they obtained a source of funding. The different studies are of variable quality (Table [4](#Tab4){ref-type="table"}), from satisfactory (i.e., 5/9 points) to excellent (i.e., 9/9 points) as defined arbitrarily. Studies of lesser quality usually have difficulties in representativeness of the sample. Table 3Characteristics of studies*First author, year*Population\
*"n" and type of population*\
*Sex ratio*Time of follow-upMeasure of bone quantity\
*Unit*\
*Site(s)*\
*Tool*Measure of muscle componentsMuscle Mass\
*Unit*\
*Site*\
*Tool*Muscle strength\
*Unit*\
*Site*\
*Tool*Physical performance\
*Unit*\
*Tool*Arabi et al., 2012 \[[@CR36]\]192 older subjects (65--85 years)66.7% of male4.2 yearsBone mineral densityHip, femoral neck, lumbar spineDEXALean massSubtotal bodyDEXABleicher et al., 2011 \[[@CR38]\]1114 older menNot applicable2.1 yearsBone mineral densityHipDEXALean massTotal bodyDEXAChen et al., 1997 \[[@CR39]\]45 postmenopausal womenNot applicable1 yearBone mineral densityHip, femoral neck, lumbar spine, total bodyDEXALean massTotal bodyDEXAHrafnkelsson et al., 2013 \[[@CR31]\]164 school children of 7 years57.3% of male2 yearsBone mineral densityHip, femoral neck, total bodyDEXALean massTotal bodyDEXALiu-Ambrose et al., 2006 \[[@CR22]\]53 premenopausal womenNot applicable12 yearsBone mineral densityHip, lumbar spine, total bodyDEXALean massTotal bodyDEXAMilliken et al., 2009 \[[@CR29]\]167 postmenopausal women (40--65 years)Not applicable4 yearsBone mineral densityHip, femoral neckDEXALean massTotal bodyDEXACadogan et al., 1998 \[[@CR34]\]182 elderly community-dwelling womenNot applicable2 yearsBone mineral densityTotal bodyDEXALean massTotal bodyDEXAVicente-Rodriguez et al., 2005 \[[@CR27]\]42 prepubertal boysNot applicable3.3 yearsBone mineral densityHip, femoral neckDEXALean massTotal bodyDEXAYoung et al., 2001 \[[@CR25]\]286 female twins aged 8--26 yearsNot applicable1.8 yearsBone mineral densityHip, femoral neck, lumbar spineDEXALean massTotal bodyDEXAHeidemann et al., 2015 \[[@CR32]\]683 children (preschool to 4th grade)50.9% of male2 yearsBone mineral contentTotal bodyDEXALean massSubtotal bodyDEXAWang et al., 2007 \[[@CR26]\]221 pubertal girls (10--13 years)Not applicable2 yearsBone mineral contentTotal body, left arm, left legDEXAMaximal Isometric Voluntary Contractionleft elbow flexors, left leg extensorsDynamometer chairSirola et al., 2006 \[[@CR28]\]971 peri- and postmenopausal womenNot applicable5.9 yearsBone mineral densityLumbar spine, femoral neckDEXAKilopascalHandgripPneumatic dynamometerSirola et al., 2006 \[[@CR11]\]587 peri- and postmenopausal womenNot applicable10.3 yearsBone mineral densityLumbar spine, femoral neckDEXAKilopascalHandgripPneumatic dynamometerSirola et al., 2005 \[[@CR37]\]622 peri- and postmenopausal womenNot applicable10.3 yearsBone mineral densityLumbar spine, femoral neckDEXAKilopascalHandgripPneumatic dynamometerKwon et al., 2007 \[[@CR30]\]182 elderly community-dwelling womenNot applicable2 yearsBone mineral densityForearmDEXAWalking speed5-m Table 4Newcastle-Ottawa Scale score for included studies*Studies*Total score (/9 points)Arabi et al., 2012 \[[@CR36]\]7 pointsBleicher et al., 2011 \[[@CR38]\]9 pointsChen et al., 1997 \[[@CR39]\]8 pointsHrafnkelsson et al., 2013 \[[@CR31]\]8 pointsLiu-Ambrose et al., 2006 \[[@CR22]\]8 pointsMilliken et al., 2008 \[[@CR29]\]8 pointsCadogan et al. \[[@CR34]\],8 pointsVicente-Rodriguez et al., 2005 \[[@CR27]\]7 pointsYoung et al., 2001 \[[@CR25]\]5 pointsHeidemann et al. \[[@CR32]\],6 pointsWang et al., 2007 \[[@CR26]\]7 pointsSirola et al., 2006 \[[@CR11]\]7 pointsSirola et al., 2005 \[[@CR28]\]7 pointsSirola et al., 2006 \[[@CR37]\]7 pointsKwon et al., 2007 \[[@CR30]\]9 points

Relationship between changes in bone mass and changes in lean mass {#Sec11}
------------------------------------------------------------------

We have therefore identified 10 articles focusing on the parallel evolution of bone and lean mass. In regards of clinical considerations, we separated our analysis in two ways:

When the measurement of the BMD at different sites of the skeleton corresponding to the measurement of different bone compartments whose trabecular bone and cortical bone content was variable, we decided to perform a meta-analysis per measurement site of this BMD.

The bone mineral content (BMC) can significantly differ from bone mineral density, so the study of Heidemann et al. (2015) \[[@CR33]\], which focused only on BMC, was analyzed separately with a narrative report.

### Hip bone mineral density and lean mass {#Sec12}

The 8 analyzed studies \[[@CR22], [@CR25]--[@CR27], [@CR30], [@CR32], [@CR37], [@CR39]\] comprised a total of 2022 patients. Their quality varied by 5 points in the NOS score \[[@CR25]\] under the maximum score of 9 points \[[@CR39]\] (Table [4](#Tab4){ref-type="table"}). Three studies reported an analysis of children's health \[[@CR25], [@CR27], [@CR32]\], and 5 studies were about postmenopausal or older subjects \[[@CR22], [@CR30], [@CR37], [@CR39], [@CR40]\]. The association between the evolution of hip BMD and the evolution of lean mass was significantly correlated in all studies except for that of Chen et al. (1997) \[[@CR40]\] (*p*-value \> 0.05) and Hrafnkelsson et al. (2015) \[[@CR32]\] (*p*-value\> 0.05). The correlation coefficients r varied from 0.05 \[[@CR40]\] to 0.69 \[[@CR27]\] (Fig. [2](#Fig2){ref-type="fig"}). Among these results, the correlation coefficients r were imputed from the available β coefficient for all of the studies except for that of Liu-Ambrose et al. (2006) \[[@CR22]\] and that of Vicente-Rodriguez et al. (2005) \[[@CR27]\]. A meta-analysis was performed to combine the results of these different studies (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Association between changes in hip bone mineral density and changes in lean mass: a meta-analysis

An overall correlation coefficient r of 0.37 (95% CI 0.23--0.49, *p*-value \< 0.001) was yielded by pooling the results of the 8 studies, indicating that the prospective changes in hip BMD were significantly and moderately correlated to the changes in lean mass. The subgroup analysis indicated that there was a significant difference in effect size (*p*-value\< 0.001) between that of children (3 studies, r = 0.43 (95% CI: 0.06--0.69)) and that of adults and older individuals (5 studies, r = 0.34 (95% CI 0.19--0.48)). There was heterogeneity in our meta-analysis (I^2^ = 86.99, *p*-value\< 0.001), so a meta-regression was performed to explore this phenomenon. We found no significant impact at the level of the quality of study, the mean age analyzed, the sex or the duration of the follow-up on the overall effect size (all *p*-values\> 0.05). The Eggers' regression analysis demonstrated that publication bias was not present (*p*-value = 0.27). The one-way sensitivity analysis showed the consistency of our results, showing that they had roughly the same correlation coefficient, and the heterogeneity I^2^ value exceeded 85.75% in all cases.

### Femoral neck bone mineral density and lean mass {#Sec13}

Four studies of a total of 649 individuals investigated the relationship between femoral neck change and lean mass change \[[@CR25], [@CR30], [@CR37], [@CR40]\], and the methodological quality ranged from satisfactory \[[@CR25]\] to good \[[@CR30], [@CR37], [@CR40]\]. The studies focused on adulthood (i.e., in this case, premenopausal women) except one that focused on childhood \[[@CR25]\]. Only one study, that of Chen et al. (1997) \[[@CR40]\], found no significant association between the evolution of femoral neck BMD and the evolution of lean mass. The set of correlation coefficients is available in Fig. [3](#Fig3){ref-type="fig"}, demonstrating a pooled correlation coefficient r of 0.33 (95% CI 0.16--0.49), a value that is moderate but significant. Fig. 3Association between changes in femoral neck bone mineral density and changes in lean mass: a meta-analysis

A subgroup analysis was not feasible since there was only one study in the 'children' group. Heterogeneity was found in this analysis (I^2^ = 79.06, *p*-value = 0.002). When we inserted moderators into the meta-regression, we observed that the quality level of the study, the mean age, the sex and the duration of follow-up did not have a significant impact on the pooled effect size (all *p*-values\> 0.05). The Eggers' regression test showed there was no publication bias (*p*-value = 0.24). A one-way analysis allowed us to determine that the study of Young et al. (2011) \[[@CR25]\] had a significant influence on the meta-analysis model. Indeed, when this study was removed from the pooling, the heterogeneity was much lower and not significant (I^2^ = 22.36, *p*-value = 0.28). In this case, the pooled correlation coefficient raised up to 0.42, showing that, through the sensitivity analysis, the study of Young et al. was source of heterogeneity, probably due to its focus on another population (ie., young female twins).

### Lumbar spine bone mineral density and lean mass {#Sec14}

The four studies examining the prospective link between the evolution of lumbar spine BMD and the evolution of the lean mass were the same as the four studies described in the paragraph above, and they therefore have the same characteristics \[[@CR25], [@CR30], [@CR37], [@CR40]\]. One study showed no significant association between the two entities tested \[[@CR40]\]. The overall correlation coefficient r was 0.32 (95% CI 0.19--0.43), modest to substantial heterogeneity between studies was observed (I^2^ = 60.91, *p*-value = 0.05) (Fig. [4](#Fig4){ref-type="fig"}), and the one-way sensitivity analysis confirming this finding by demonstrating that the value of I^2^ remained in the same range. When considering the quality level of the study, neither the mean age nor the duration of follow-up as moderators within a meta-regression, neither of those nor significantly stood out as moderators within the meta-regression (all *p*-values \> 0.05). After applying Egger's regression analysis, no publication bias was established (*p*-value = 0.33). Fig. 4Association between changes in lumbar spine bone mineral density and changes in lean mass: a meta-analysis

### Total body bone mineral density and lean mass {#Sec15}

The three studies included a total of 246 patients in this meta-analysis. Two studies were focused on childhood \[[@CR32], [@CR35]\], and one in older subjects \[[@CR40]\], and all were of good quality (NOS score = 8 points for all). One unique study by Chen et al. (1997) \[[@CR40]\] showed no significant association between the changes in the two entities tested. When we pooled results of all studies, a correlation coefficient r of 0.53 was yielded (95% CI -0.23-0.89) and was not significant (*p*-value = 0.16) (Fig. [5](#Fig5){ref-type="fig"}). A large heterogeneity was found (*p*-value \< 0.001). After performing the one-way analysis (i.e., one-to-one model withdrawal), heterogeneity remained high and significant. Specifically, the study by Cadogan et al. reported a much higher r value than any of the other included studies. No specific difference with others studies was noted regarding general characteristics. Fig. 5Association between changes in total body bone mineral density and changes in lean mass: a meta-analysis

A meta-regression could not be applied since too few studies were included. Finally, we did not find the presence of a publication bias, given that the *p*-value of Egger's regression equaled 0.57.

### Bone mineral content and lean mass {#Sec16}

The study of Heidemann et al. (2015) \[[@CR33]\] was not focused on the changes of BMD but rather in the changes of BMC. Therefore, this study required a separate analysis. The research was focused on children over a two-year follow-up period and appeared to be of satisfactory quality (6 points out of 9). Heidemann et al. (2015) pointed out in their regression model that bone content accretion was significantly predicted by changes in lean mass (*p*-value \< 0.001).

Relationship between changes in bone mass and changes in muscle strength {#Sec17}
------------------------------------------------------------------------

Three studies examined the link between the evolution of the BMD and that of muscle strength, in peri- or postmenopausal women \[[@CR28], [@CR29], [@CR38]\]. However, since these three studies were performed by the same author, we did not perform a meta-analysis because that the samples likely overlap. In addition, two of these three studies appeared to focus on the same cohort of subjects. All three studies conclude that there is a statistically significant association between decreased muscle strength in postmenopausal women and bone loss (*p*-values \< 0.05). For these studies, no correlation coefficient was calculated, and the authors demonstrated an association simply based on differences in bone loss rate between those with increased grip strength and those with having decreased grip strength. These three studies are of fairly good quality (7 out of 9 points).

Then, the study of Wang et al. (2007) \[[@CR26]\], which was conducted on children two years of age, also showed that the change of BMC (but not the BMD) was significantly correlated with the change of volumetric contraction strength in the limbs (r ≥ 0.22, *p*-value \< 0.05). This study was of satisfactory quality (6 out of 9 points).

Relationship between changes in bone mass and changes in physical performance {#Sec18}
-----------------------------------------------------------------------------

Finally, the study by Kwon et al. (2007) \[[@CR31]\], investigated the link between BMD changes and changes in physical performance, as measured by the 5-m usual walking speed; this study was on older women and was methodologically excellent (9 points). This study concluded that a decline in BMD was significantly related to a decline in usual walking speed (correlation coefficient r = 0.21, *p*-value = 0.004).

Discussion {#Sec19}
==========

In this work we have synthesized data from the literature concerning the link between the evolution of skeletal status (specifically, BMD) and of various muscle components. Fifteen studies were included in our analysis, 10 of which were related to lean mass, 4 to muscle strength, and 1 to physical performance.

Association between changes in bone mineral density and changes in lean mass {#Sec20}
----------------------------------------------------------------------------

Using a meta-analysis approach, our results showed a significant association between the evolution of the bone mass and that of the mass muscle. The overall correlation coefficient r was significant and equal to 0.37 when considering bone hip density, 0.33 for femoral neck BMD and 0.32 for the lumbar spine. One notable exception, however, was that the link was not significant when measuring the bone density of the whole body (*p*-value = 0.16). However, this BMD measurement site does not appear optimal and would tend to overestimate the BMD and thereby underestimate osteopenia \[[@CR41]\]. If one omits the unreliable results concerning the total body BMD, the magnitude of the correlation at the different sites seems to be the same (r varies from 0.32 to 0.37); this outcome suggests the same general trend of parallel evolution in the two entities of bone and muscle regardless of the measurement site.

A clear significant link was found (*p*-value \< 0.001) between the two bone and lean mass, but it was moderate and thus one only partially explained the evolution of the other. Other factors should therefore be taken into account when considering the evolution of the masses of the bone-muscle unit (e.g., genetics; the genes that have been identified for their implications in sarcopenia \[[@CR42]\] appear to be different from those involved in osteoporosis \[[@CR43]\]). Evaluating the bone mass by using BMD or BMC measurements did not appear to influence the conclusions about the association between the two parameters.

The quite obvious relationship in development during the evolution of the bone mass and the lean mass could be explained mainly by mechanics: the muscle mass, which develops following a physical activity or an adapted dietary intake, will exert a net tension at the level of muscle insertion on the bone, resulting in a bone accruement \[[@CR31], [@CR44]\]. During the maturing phase and the aging process, the opposite was observed: the physiological changes are linked to decreased physical activity, and a change in nutritional status leads to a decline in lean mass, thus no longer exerting its mechanistic effect on the bones of the body and causing a simultaneous decline in bone mass. Our study shows that this link is more marked during childhood and therefore during the developmental process (r = 0.43) than during the aging process (r = 0.34). We hypothesize that this significant difference in effect (*p* \< 0.001) may be related to multiple other influencing factors (such as diet, gene expression, peak bone and lean mass acquired during childhood, \...) that have had the time to impact musculoskeletal health during adulthood and aging. Indeed, only a partial proportion of the association in changes was explained by the relationship between bone and muscle (i.e., less of 15% of the variance accounted for): other clinical implications have to be considered.

Association between changes in bone mineral density and changes in muscle strength {#Sec21}
----------------------------------------------------------------------------------

Few studies have been identified regarding this aspect: 3 studies by the same author, and one in children. In both situations, we found significant associations. Although no meta-analysis could be done, these studies revealed a link between the evolution of muscle strength and that of the BMD. A biological plausibility can hypothetically explain this observed association: that of mechanical strain of the muscle on bone tissue metabolism \[[@CR12], [@CR45]\].

Association between changes bone mineral density and changes in muscle performance {#Sec22}
----------------------------------------------------------------------------------

We have only one study regarding the relationship of the evolution of the BMD compared to that of physical performance, although this issue deserves further investigation. There are many studies on whether physical performance (weak or good) is a determinant of low or good bone mass \[[@CR46]\] but not on if there is a parallel evolution between the two entities, although this is a more preventive idea. However, in the only study that highlighted the link between bone mass and physical performance, the correlation was significant albeit moderate (r = 0.21). This significant association could be explained by the direct link between the physical function (and by this, the performance) and the muscle action on the bone, as emphasized previously by several authors \[[@CR31], [@CR44]\].

Strengths and limitations {#Sec23}
-------------------------

This study is the first to employ a meta-analysis to synthetize the results from studies examining an association between the parallel evolution of bone and muscle status. One asset of our study is that we looked in multiple databases, although some databases could not be consulted following logistical barriers. All processes have been rigorous, using the PRISMA statements to ensure a good level of reporting of our research. In addition, our meta-analysis has highlighted a gap in the scientific literature on our theme: few studies exist in older men and few studies focus on certain muscle components (i.e., changes in muscle strength and changes in physical performance). These areas deserve to be more studied. Our present analysis, however, has certain limitations, so it is necessary to consider its interpretation in the context of these limitations. First, even though we made every effort to contact the authors to obtain the missing data that was essential for the quantitative synthesis of the results, the majority of the authors did not answer our calls. Therefore, we had to resort to a technical imputation of the correlation coefficient r from the coefficient β. This technique is mathematically developed and has proved its merits in order to pool the results of a meta-analysis. Indeed, it seems preferable to impute the data rather than to omit the studies interested in the topic, which could have led to a bias. However, the limitations of the method are important. First, the correlation coefficient obtained is not real data, so we must interpret them with caution. Also, the fact of using in the meta-analysis the correlation coefficients does not allow, by definition, to consider in the statistical relationship the potential confounding factors.

We also identified the potential sources of clinical and statistical heterogeneity among the included references: the sex of the subjects studied, the quality of the studies, and the diverse duration of follow-up and age-group of interest (i.e., differences in protocols). However, we have taken these parameters into account by using a random-effect model and performing subgroup or meta-regression analyses, showing no effect of duration of follow-up but significant differences in outcomes between children and adults (i.e., the association is significantly greater in children than in adults). Inclusion of studies with short follow-up may lead to bias as the minimum duration to observe change in bone and muscle in a non-diseased population is at minimum 2 years \[[@CR47]\]. We hypothesize that this heterogeneity could also be induced by the small number of studies that were included in each of the meta-analyses, and other good quality studies should be conducted to reinforce our analysis, despite the fact that this statement seems clear (i.e., although there is indeed a significant association, it seems moderate). It should also be noted that there remains a possibility that our analysis has necessarily excluded unpublished studies concerning our theme, representing a threat to its validity. However, the publication bias was evaluated and did not show any bias at this level even if some relevant papers could always be missed. Finally, it should also be recognized that the instrument that was used to measure the methodological quality of the studies also had its limitations, particularly in terms of its interpretation. This could influence our descriptive but also statistical analysis (i.e., the results of the meta-regression). Next, we have studied in this meta-analysis the magnitude of bone-muscle associations, by pooling the correlation coefficient r of all studies, regardless of sex and life-stage. It is legitimate to group together these coefficients, since we seek here to describe the intensity of the relationship. However, subgroup analyzes were performed as well as meta-regressions considering its covariates. We have therefore concluded that the intensity of the "bone-muscle" association is even higher during childhood, but no effect has been established with regard to sex. There are however sub-groups for which we do not have sufficient data, which represent a limit of our meta-analysis. Finally, DXA bone site and site of muscle measure might be different, resulting in overall lower correlation. For the studies that used DXA to measure muscle, we noted that lean mass is not equivalent to muscle mass: some care should be made in interpreting these results.

Conclusion {#Sec24}
==========

Our analysis highlighted a structural relationship between the changes, both during childhood and during the aging process, of bone mass and of markers of muscle function. There appear to be one or more factors linking decline in bone and muscle and hence interventions may well impact the concurrent decline in muscle and bone. Further research would be necessary to elucidate whether interventions targeting bone and/or muscle would be effective in altering this concurrent decline.
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